EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients

Clinical trial NCT04444921 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04444921
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Anal Basaloid Carcinoma Anal Canal Cloacogenic Carcinoma Metastatic Anal Squamous Cell Carcinoma Recurrent Anal Squamous Cell Carcinoma Stage III Anal Cancer AJCC v8 Stage IV Anal Cancer AJCC v8 Unresectable Anal Squamous Cell Carcinoma

Start date: 2020-11-17
Primary completion: 2027-03-31
Enrollment: 205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.